Quebec platelet disorder: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
 
CSV import
Line 27: Line 27:


{{stub}}
{{stub}}
<gallery>
File:Autosomal_dominant_-_en.svg|Autosomal dominant inheritance pattern
</gallery>

Revision as of 21:36, 20 February 2025

Quebec Platelet Disorder (QPD) is a rare bleeding disorder that is characterized by a deficiency in the blood platelets' ability to clot. This disorder is unique to certain families in the province of Quebec, Canada, hence its name.

Symptoms

The symptoms of Quebec Platelet Disorder include bruising, nosebleeds, gastrointestinal bleeding, and menorrhagia (heavy menstrual bleeding). These symptoms are due to the inability of the blood platelets to clot properly, leading to excessive bleeding.

Causes

Quebec Platelet Disorder is caused by a mutation in the gene that codes for the production of plasminogen activator inhibitor-1 (PAI-1), a protein that inhibits the breakdown of blood clots. This mutation results in an overproduction of PAI-1, leading to a decrease in the ability of the blood platelets to clot.

Diagnosis

The diagnosis of Quebec Platelet Disorder is based on the presence of the characteristic symptoms, a family history of the disorder, and laboratory tests that show an increase in the level of PAI-1 in the blood.

Treatment

The treatment of Quebec Platelet Disorder is aimed at controlling the symptoms and preventing bleeding episodes. This may include the use of antifibrinolytic drugs, which help to stabilize blood clots and prevent them from breaking down.

See also

References

<references />

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia